Actionable news
All posts from Actionable news
Actionable news in ABBV: ABBVIE Inc,

Abbvie Hep C Drug Safety Warning Prompts Panic Selling, Totally Unjustified

Abbvie (ABBV - Get Report) shares plunged as much as 15% Thursday afternoon after U.S. regulators issued a safety warningtying its hepatitis C drugs to an increased risk of serious liver injury.

Investors are totally over-reacting to what might be a small hit to Abbvie's hepatitis C revenue.

That's because Abbvie's hepatitis C drugs Viekira Pak and Technivie are already not recommended or approved for hepatitis C patients with underlying, severe liver disease such as cirrhosis. Doctors shouldn't be prescribing the drugs to these advanced liver disease patients, yet...